Regulating the NMDA/NR2B signaling pathway mediates anticonvulsant, antineuroinflammation, and anti-oxidative stress effects of 1,3,benzothiazole derivative 1M in pentylenetetrazole-induced kindling in mice.

Autor: Qazi NG; Department of Pharmacy, Iqra University, Islamabad, 46000, Pakistan. dr.nenogull@gmail.com., Malik AS; Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, 46000, Pakistan., Alvi AM; Faculty of Pharmacy, Ibadat International University, Islamabad, 46000, Pakistan., Ali F; Department of Pharmacy, Kohat University of Science and Technology, Kohat, 26000, Pakistan., Badshah I; Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, 46000, Pakistan., Nadeem H; Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, 46000, Pakistan., Malik SZ; Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, 46000, Pakistan. sohaib.zafar@riphah.edu.pk.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating Nrf2-Pathway

Autor: Alvi AM, Shah FA, Muhammad AJ, Feng J, Li S

Publikováno v: Journal of Inflammation Research, Vol Volume 14, Pp 7393-7409 (2021)

Arooj Mohsin Alvi,1,2 Fawad Ali Shah,2 Asmaa Jan Muhammad,2 Jinxing Feng,1 Shupeng Li3 1Department of Neonatology, Shenzhen Children’s Hospital Shenzhen, Shenzhen, People’s Republic of China; 2Department of Pharmacology, Riphah Institute of Pharm

Externí odkaz: https://doaj.org/article/8dc89d83a26a4e9584b8ab7e82122b22

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats [Retraction]

Autor: Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S

Publikováno v: Journal of Inflammation Research, Vol Volume 15, Pp 6069-6070 (2022)

Zulfiqar Z, Shah FA, Shafique S, et al. J Inflamm Res. 2020;13:1185–1205. The Editor and Publisher of Journal of Inflammation Research wish to retract the published article. Concerns were raised regarding the duplication of several images from Figu

Externí odkaz: https://doaj.org/article/452d8cd61e7b4bff8b9476aa80f8ab8a

Survival Outcomes in Malignancy-related Hypercalcemia: A Tertiary Care Single-center Experience.

Autor: Ashfaq S; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Shafiq W; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Siddiqi AI; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Azmat U; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Irfan H; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Khan SA; Department of Endocrinology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Alvi AM; Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Bakar MA; Department of Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Hassan M; Department of Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Farooq A; Department of Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Sheikh AZ; Department of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Siddique K; Department of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Asghar K; Department of Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Publikováno v: Journal of cancer & allied specialties [J Cancer Allied Spec] 2024 Aug 16; Vol. 10 (2), pp. 675. Date of Electronic Publication: 2024 Aug 16 (Print Publication: 2024).

Leniolisib: a drug providing a promising avenue for the treatment of activated phosphoinositide 3-kinase δ syndrome (APDS).

Autor: Ali A; Agha Khan University hospital (AKU)., Qureshi A; Agha Khan University hospital (AKU)., Shigri AF; Agha Khan University hospital (AKU)., Alvi AM; Agha Khan University hospital (AKU) Karachi, Pakistan., Malikzai A; Kabul Medical University, Kabul, Afghanistan.

Publikováno v: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 May 20; Vol. 86 (7), pp. 3812-3813. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).